Skip to main content
. 2023 May 22;15(5):1561. doi: 10.3390/pharmaceutics15051561

Figure 4.

Figure 4

The influence of G. robertianum extracts on the development of CPE in HHV-1-infected VERO cells. (A) VERO cell control; HHV-1 infected VERO cells treated with GrH 150 µg/mL (B), GrH 125 µg/mL (C), GrH 100 µg/mL (D), GrEA 150 µg/mL (F), GrEA 125 µg/mL (G), GrEA 100 µg/mL (H); (E) Virus control, HHV-1 infected and non-treated VERO cells.